RTI Surgical enrolls 1st patient in 3D-printed implant study — 3 insights

Angie Stewart -   Print  |

RTI Surgical enrolled the first patient in a clinical evaluation of its Fortilink Interbody Fusion 3D-printed implants for degenerative disc disease treatment, 3D Printing Industry reports.

Three insights:

1. With RTI Surgical's TETRAfuse 3D technology, the Fortilink implants offer 3D-printed nano-rough surfaces.

2. The devices are designed to improve protein absorption, bioactivity, cell adhesion and tissue growth for fusion in cervical and lumbar surgeries.

3. The clinical study will evaluate the performance of Fortilink-C, -TS and -L IBF implants, comparing their cages to other cage materials. Over a 3.5-year period, researchers will study the implants' effectiveness in 150 patients from 20 U.S. healthcare facilities.

More articles on surface technology:
FDA clears Nvision Medical Technology's foot and ankle implant: 3 insights
Orthopaedic Implant Company enters sports medicine market with PEEK anchor system: 3 insights
5 things to know about the vertebral body replacement device market

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers